Literature DB >> 16691018

Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL.

Miri Holtser-Cochav1, Inna Divinski, Illana Gozes.   

Abstract

The authors set out to investigate whether NAP-related peptides interact with tubulin at a NAP binding site. Previous studies have shown that the neuroprotective peptide NAP binds to tubulin. As NAP (NAPVSIPQ) shares structural similarities with ADNF-9 (SALLRSIPA), and the all-D-enantiomers, D-NAP and D-SAL, it was hypothesized that all of these peptides compete with NAP-tubulin binding. Using NAP affinity column and extracts from newborn rat brain (cerebral cortex), we now show that the above-mentioned peptides compete with NAP binding to tubulin. The identification of tubulin as a target binding site for NAP-related peptides explains, in part, the broad neuroprotective activity offered by these potent peptides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16691018     DOI: 10.1385/JMN:28:3:303

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  33 in total

1.  Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.

Authors:  D E Brenneman; J Hauser; E Neale; S Rubinraut; M Fridkin; A Davidson; I Gozes
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

2.  Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation.

Authors:  Q Guo; L Sebastian; B L Sopher; M W Miller; G W Glazner; C B Ware; G M Martin; M P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  Microtubule protein: tubulin.

Authors:  I Gozes; U Z Littauer
Journal:  Scand J Immunol Suppl       Date:  1982

4.  Tubulin microheterogeneity increases with rat brain maturation.

Authors:  I Gozes; U Z Littauer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

5.  Multiple tubulin forms are expressed by a single neurone.

Authors:  I Gozes; K J Sweadner
Journal:  Nature       Date:  1981-12-03       Impact factor: 49.962

6.  Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

Authors:  D Offen; Y Sherki; E Melamed; M Fridkin; D E Brenneman; I Gozes
Journal:  Brain Res       Date:  2000-01-31       Impact factor: 3.252

7.  Cloning and characterization of the human activity-dependent neuroprotective protein.

Authors:  R Zamostiano; A Pinhasov; E Gelber; R A Steingart; E Seroussi; E Giladi; M Bassan; Y Wollman; H J Eyre; J C Mulley; D E Brenneman; I Gozes
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

8.  Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes.

Authors:  Sharon Furman; Ruth A Steingart; Shmuel Mandel; Janet M Hauser; Douglas E Brenneman; Illana Gozes
Journal:  Neuron Glia Biol       Date:  2004-08

9.  NAP mechanisms of neuroprotection.

Authors:  Illana Gozes; Ruth A Steingart; Avron D Spier
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Vasoactive intestinal peptide and electrical activity influence neuronal survival.

Authors:  D E Brenneman; L E Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

View more
  9 in total

1.  Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.

Authors:  Rafael Fernandez-Montesinos; Manuel Torres; David Baglietto-Vargas; Antonia Gutierrez; Illana Gozes; Javier Vitorica; David Pozo
Journal:  J Mol Neurosci       Date:  2009-10-21       Impact factor: 3.444

2.  The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules.

Authors:  Mythili Yenjerla; Nichole E LaPointe; Manu Lopus; Corey Cox; Mary Ann Jordan; Stuart C Feinstein; Leslie Wilson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.

Authors:  Tomohiro Chiba; Ikuo Nishimoto; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

4.  D-SAL and NAP: Two Peptides Sharing a SIP Domain.

Authors:  Illana Gozes; Shlomo Sragovich; Yulie Schirer; Anat Idan-Feldman
Journal:  J Mol Neurosci       Date:  2016-06       Impact factor: 3.444

Review 5.  D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.

Authors:  Yan Jouroukhin; Regina Ostritsky; Illana Gozes
Journal:  J Mol Neurosci       Date:  2012-11       Impact factor: 3.444

6.  Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model.

Authors:  Sinaya Vaisburd; Zeev Shemer; Adva Yeheskel; Eliezer Giladi; Illana Gozes
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

7.  Microtubule stabilising peptides rescue tau phenotypes in-vivo.

Authors:  Shmma Quraishe; Megan Sealey; Louise Cranfield; Amritpal Mudher
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

8.  NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).

Authors:  Illana Gozes; Inna Divinski; Inbar Piltzer
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

9.  ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect.

Authors:  Illana Gozes; Yanina Ivashko-Pachima; Carmen L Sayas
Journal:  Front Mol Neurosci       Date:  2018-05-01       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.